Mother-Baby Study - Caloric Compensation Index (COMPX)
Launched by UNIVERSITY OF MICHIGAN · Oct 2, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Mother-Baby Study, also known as the Caloric Compensation Index (COMPX), is researching how mothers and their infants interact when it comes to emotions and eating habits. The goal is to understand how these interactions can affect what mothers feed their babies, how babies eat, and their overall health, including their weight. This study will look at the connections between a mother’s feelings, her attachment to her baby, and how these factors influence both their eating behaviors.
To join this study, your infant must already be part of a long-term observational study. The trial is open to all infants, starting from birth. If you participate, you can expect to engage in activities that help researchers learn more about the relationship between mothers and their babies during feeding times. This study aims to help improve understanding of healthy eating behaviors in both mothers and infants, which is important for their overall well-being.
Gender
ALL
Eligibility criteria
- • The child is a participant in the observational study (NCT06039878).
About University Of Michigan
The University of Michigan, a leading academic institution renowned for its commitment to advancing healthcare and medical research, serves as a prominent clinical trial sponsor. With a robust infrastructure that supports innovative research initiatives, the university leverages its multidisciplinary expertise to conduct a wide array of clinical trials aimed at improving patient outcomes and advancing medical knowledge. Through its state-of-the-art facilities and collaborative environment, the University of Michigan fosters partnerships between researchers, clinicians, and industry leaders, ensuring the development of cutting-edge therapies and interventions that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ann Arbor, Michigan, United States
Patients applied
Trial Officials
Julie Lumeng, MD
Study Chair
University of Michigan
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported